What is your brain tumor story? Click here to share it and be part of the community!
Being diagnosed with a serious medical condition can feel overwhelming. One of the biggest questions many people have is, “Where should I go for treatment?”” This is especially true for those diagnosed with a primary or metastatic (secondary) brain or central nervous system (CNS) tumor. Choosing the right treatment center is an important step, and these key principles can guide you and your loved ones in making the best decision with the support and education you deserve.
American Brain Tumor Association
Brain Tumor Network
CERN Foundation
Head for the Cure
International Brain Tumor Alliance
Musella Foundation
National Brain Tumor Society
Oligo Nation
Society for NeuroOncology
Southeastern Brain Tumor Foundation
The Brain Tumor Charity
When diagnosed with a serious medical condition, patients want to know that they are receiving the best possible medical care from a medical professional or institution. This is especially true for those diagnosed with a primary or metastatic (secondary) central nervous system (CNS) tumor, who often ask “Where should I get treated?”
The guiding principles for adult CNS tumor treatment centers, which generally correlate with quality brain tumor care, exist to help patients and their loved ones select the best care possible based on their individual needs. They are meant to be used as a tool for education and guidance.
This medical institution offers a program dedicated to the treatment of adults with CNS (brain, spine, cranial nerves, meninges) tumors. This program has specialist clinical staff trained in the diagnosis, treatment, and care of adult patients diagnosed with CNS tumors.
This CNS tumor treatment program treats at least 40 adult patients diagnosed with primary CNS tumors per year. If this program treats metastatic CNS tumors, at least 20 adult patients diagnosed with metastatic CNS tumors are treated per year.
This CNS tumor treatment program has a designated CNS multidisciplinary team which includes at least one of each type of the following specialists, each devoting at least 40% of their clinical hours to the treatment of CNS tumors, and each specialist must either be on-site or at an affiliated medical institution or practice:
This CNS tumor treatment program performs either on-site or outsourced testing for molecular diagnostics to determine accurate tumor diagnosis, inform prognosis, and guide treatment. Testing is done in accordance with the latest World Health Organization (WHO) criteria and performed in an accredited laboratory.
This CNS tumor treatment program offers clinical trials for CNS tumors and/or actively navigates patients to other medical centers that provide clinical trials for CNS tumors.
This CNS tumor treatment program has a multidisciplinary clinical tumor board that meets regularly, either in-person or virtually, to discuss and streamline patient care and the management of patients with CNS tumors.
This CNS tumor treatment program (or its closely affiliated medical institution or practice) offers a range of clinical supportive services that are accessible to patients and their caregivers. Examples of clinical supportive services include but are not limited to the following: neuropsychological evaluation, psychological intervention, cognitive rehabilitation, speech therapy, physical/occupational therapy, palliative care, oncology social work, patient navigation, brain tumor support group, survivorship service, and caregiver support service.
A working group, lead by the ABTA, was formed to determine a set of guiding principles by which adult CNS tumor treatment programs in the U.S. could be assessed for offering quality in treatment and care either within or near the patient’s community.
Members of the working group included representatives not-for-profit and other patient advocacy organizations serving the brain tumor community. In addition, clinicians in the brain tumor field reviewed and provided input.
The working group acknowledges that a program that adheres to these guiding principles does not necessarily guarantee the best possible medical care. Similarly, a program that does not adhere to all of these guiding principles can still provide quality care. The working group advocates for these guiding principles to be used as an aspirational framework, upon which treatment centers could build elements of CNS tumor care.
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
Make an end-of-year gift now and your gift will be matched thanks to the family of Connie Fischer.